The Food and Drug Administration on Friday approved Pfizer’s treatment for a rare genetic bleeding disorder, making it the company’s first-ever gene therapy to win clearance in the U.S. The agency ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results